KZR Kezar Life Sciences Inc

USD 0.90 0.00 -0.155039
Icon

Kezar Life Sciences Inc (KZR) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.9016

0.00 (-0.16)%

USD 0.07B

1.17M

USD 2.00(+121.83%)

N/A

Icon

KZR

Kezar Life Sciences Inc (USD)
COMMON STOCK | NSD
USD 0.90
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.07B

N/A

USD 0.90

Kezar Life Sciences Inc (KZR) Stock Forecast

Show ratings and price targets of :
USD 2.00
(+121.83%)

Based on the Kezar Life Sciences Inc stock forecast from 2 analysts, the average analyst target price for Kezar Life Sciences Inc is USD 2.00 over the next 12 months. Kezar Life Sciences Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Kezar Life Sciences Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Kezar Life Sciences Inc’s stock price was USD 0.9016. Kezar Life Sciences Inc’s stock price has changed by -6.57% over the past week, -13.31% over the past month and -71.91% over the last year.

No recent analyst target price found for Kezar Life Sciences Inc
No recent average analyst rating found for Kezar Life Sciences Inc

Company Overview Kezar Life Sciences Inc

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib ...Read More

4000 Shoreline Court, South San Francisco, CA, United States, 94080

58

December

USD

USA

Adjusted Closing Price for Kezar Life Sciences Inc (KZR)

Loading...

Unadjusted Closing Price for Kezar Life Sciences Inc (KZR)

Loading...

Share Trading Volume for Kezar Life Sciences Inc Shares

Loading...

Compare Performance of Kezar Life Sciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for KZR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Kezar Life Sciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing KZR

Symbol Name KZR's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Kezar Life Sciences Inc (KZR) Stock

Based on ratings from 2 analysts Kezar Life Sciences Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on KZR's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for KZR is USD 2.00 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 2.

Unfortunately we do not have enough data on KZR's stock to indicate if its overvalued.

The last closing price of KZR's stock was USD 0.90.

The most recent market capitalization for KZR is USD 0.07B.

Based on targets from 2 analysts, the average taret price for KZR is projected at USD 2.00 over the next 12 months. This means that KZR's stock price may go up by +121.83% over the next 12 months.

We can't find any ETFs which contains Kezar Life Sciences Inc's stock.

As per our most recent records Kezar Life Sciences Inc has 58 Employees.

Kezar Life Sciences Inc's registered address is 4000 Shoreline Court, South San Francisco, CA, United States, 94080. You can get more information about it from Kezar Life Sciences Inc's website at https://www.kezarlifesciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...